Latest Lundbeck Stories
LA JOLLA, Calif., Dec. 16, 2010 /PRNewswire/ -- Zenobia Therapeutics, Inc. (Zenobia) the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H.
NEW YORK, Nov. 3, 2010 /PRNewswire/ -- See video from Lundbeck at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=0c5e745c-050d-4fe3-8da5-8edbb8bc6db1&bhcp=1&alertid=d0b158ec-152f-49a0-a5a9-4a7a40807750# Danish-based H.
Coalition Welcomes the LEGO Group and Lundbeck to its Ranks WASHINGTON, Nov. 2, 2010 /PRNewswire-USNewswire/ -- The Coalition Against Domain Name Abuse (CADNA) welcomes its two newest members, LEGO Juris A/S and H. Lundbeck A/S.
SANTA MONICA, Calif., Sept. 21 /PRNewswire/ -- Reprints Desk, Inc. today announced that the company will highlight the ePrints NRx scientific literature licensing and deployment service during its exhibit at the 2nd Annual DigiPharm Europe 2010 event from September 28 to October 1, 2010.
MINNEAPOLIS, June 15 /PRNewswire/ -- Orasi MedicalÂ® today announced that it has entered an agreement with H.
DEERFIELD, Ill., Oct.
DEERFIELD, Ill., Aug. 31 /PRNewswire/ -- Chicago-based Lundbeck Inc.
NEW YORK, July 10, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) and its wholly-owned subsidiary, Forest Laboratories Holdings, Ltd. (collectively, "Forest"), and H.
COPENHAGEN, March 20 /PRNewswire/ -- - On Average a Quarter of Europeans Surveyed From UK, Portugal, France, Germany, Czech Republic, Hungary and Poland Claim Worsening Quality of Sleep Thanks to the Economy(1) - Portuguese are Most Affected, With 42% Making the Admission, Compared to 17% of the UK(1) - 66% of European Adults on Average Have Experienced Problems Sleeping Over the Last 12 Months, but Only 19% of These Have Visited the Doctor(1) - Debilitating Next-Day Side...
Lundbeck has announced that the FDA has completed the initial check for completeness and accepted the new drug application on Serdolect for the treatment of schizophrenia for review.
- A hairdresser.